Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Sentient Science

Sentient Science?uq=PEM9b6PF
2001 FOUNDED
PRIVATE STATUS
51-60 EMPLOYEES
Series B LATEST DEAL TYPE
$22.5M LATEST DEAL AMOUNT
7 INVESTORS
Description

Developer of a computational testing technology intended to replace physical testing with virtual testing in materials, components, assemblies, and platforms. The company's computational testing technology helps in testing and life extension services of industrial assets in the energy, heavy machinery and defense markets, enabling users to dramatically reduce failures through computational testing, prognostic maintenance, and design optimization.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Application Software
Other Industries
Automation/Workflow Software
Other Commercial Services
Primary Office
  • 672 Delaware Avenue
  • Buffalo, NY 14202
  • United States

+1 (888) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Sentient Science’s full profile, request a free trial.

Sentient Science Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
18. Later Stage VC (Series B) 26-Jul-2017 $22.5M 000.00 0000 Completed Generating Revenue
17. Grant 12-Feb-2016 00000 000 Completed Generating Revenue
16. Later Stage VC (Series A) 13-Jan-2016 000 000 000.00 Completed Generating Revenue
15. Grant 01-Jan-2015 00000 Completed Generating Revenue
14. Grant 01-Jan-2014 00000 Completed Generating Revenue
13. Grant 29-Mar-2013 00000 Completed Generating Revenue
12. Grant 01-Jan-2013 00.000 Completed Generating Revenue
11. Grant 01-Jan-2012 00.000 Completed Generating Revenue
10. Grant 12-Oct-2011 $494K Completed Generating Revenue
9. Grant 01-Jan-2011 $1.65M Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

Sentient Science Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series B 000,000 00.000000 00.00 000.00 000.00 00 000.00 000
Series A2 000,000 00.000000 00.00 000.00 000.00 00 000.00 00.000
Series A1 97,762 $0.000100 $3.5 $43.78 $43.78 1x $43.78 9.91%
To view this company’s complete Cap Table, request access »

Sentient Science Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Georgian Partners Venture Capital Minority 000 0000 000000 0
Toba Capital Venture Capital Minority 000 0000 000000 0
U.S. Department of Energy Government 000 0000 000000 0
National Science Foundation Government 000 0000 000000 0
NYSERDA Government 000 0000 000000 0
You’re viewing 5 of 7 investors. Get the full list »

Sentient Science Executive Team (18)

Name Title Board
Seat
Contact
Info
Ward Thomas Ph.D Chief Executive Officer & President
Alfonso Faubel Chief Revenue Officer, Energy and President Europe
Brendan Harrington Chief Financial Officer
Amine Chigani Ph.D Chief Technology Officer & Vice President, Engineering
Nathan Bolander Ph.D Chief Scientist & Vice President, Research & Development

3 Former Executives

You’re viewing 5 of 18 executives. Get the full list »